Ionis Pharmaceuticals: Canaccord Genuity cuts target price to $72 from $85
IONS•Canaccord Genuity cut its target price on Ionis Pharmaceuticals to $72 from $85.
Related News
US consumer prices expected to have risen at slower pace in October
TLT•
Autoliv appoints Joachim Rosenberg as independent director
ALV•
Three workers die at Tata's India iPhone parts factory in latest safety incident
AAPL•
Onto Innovation Inc.: RBC cuts target price to $350 from $400
ONTO•
Three worker deaths occurred at effluent treatment plant operated by Ecolab's NALCO Water
ECL•